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INTRODUCTION: Non- Hodgkin’s lymphoma (NHL) mimicking Klatskin’s tumor is rare but possible. It can
be confused with tumors for which major surgery is needed. Imaging modalities have similar features in
Klatskin’s tumor and non-Hodgkin’s lymphoma.
PRESENTATION OF CASE: We herein report a patient who was ﬁrst thought having a Klatskin’s tumor
and prepared for major surgery. A month later, obstructive jaundice developed and a second magnetic
resonance-magnetic resonance cholangiopancreotography showed a doubling size of the tumor in one
month. In terms of tumor behavior, lymphoma was suspected and a tru-cut biopsy was performed by
interventional radiology. Pathological examinations revealed non-Hodgkin’s lymphoma large B-cell type.
After 4 cycles of chemotherapy by hematology-oncology department, complete cure was achieved.
DISCUSSION: Since the radiologic and clinical features are confusable inKlatskin’s tumor andnon-Hodgkin
lymphoma. Tumor biologic behavior and other biochemical parameters together may put a suspicion in
mind. Upon suspicion biopsy must be done radiologically.
CONCLUSION:Primary liver lymphomaarising fromthebileducts is extremely rare and radiologic imaging
features do not differ from cholangiocarcinoma. A strong suspicion may prevent unnecessary surgery.
Since the treatment of non-Hodgkin’s lymphoma is mainly chemotherapy.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Non-Hodgkin’s lymphoma (NHL) mimicking Klatskin’s tumor is
a relatively rare clinical entity. In the initial stagingof systemicNHL,
liver involvement is detected in 40% of patients. However, primary
liver NHL is less than 1% of all NHL’s [1]. In the literature, primary
NHLof extrahepatic bile ductswas ﬁrst reported byNguyen in 1982
[2,3]. Features of imaging studies are not clear to differentiate NHL
from cholangiocarcinoma. Major surgery is performed in most of
patients with presumptive diagnosis of cholangicarcinoma [4]. In
the literature only 20% of primaryNHL of liver is diagnosedwithout
surgery and patients are treated with chemotherapy [5].
The clinical picture is similar to Klatskin’s tumor. Jaundice, right
upper quadrant pain,weight loss are themost commoncomplaints.
Fever, nightsweats, fatigue of lymphomas can also be presented by
these patient [1].
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2. Presentation of Case
A 58 year- old female patient with type 2 diabetes mellitus and
hypertension was checked for routine follow up with biocemical
parametersandabdominalultrasonography.A liverhilusmasswith
2 cm in diameter was detected and abdominal magnetic resonance
and magnetic resonance cholangiopancreotography (MRCP) was
taken upon detection. MR and MRCP showed a 35×31mm mass
at liver hilus with intrahepatic biliary dilatation.
Laboratory ﬁndings: Total Bilirubin(TB): 0.4mg/dl, Direct Biliru-
bin(DB): 0.1mg/dl, Aspartat aminotransferase (AST): 70U/L, Ala-
nine aminotransferase(ALT): 137U/L, Alkaline phospatase (ALP):
388 U/L, Lactate dehydrogenase(LDH): 237 U/L, Gama glutamyl
transferase(GGT): 132U/L, CA19–9: 51 (0–35), WBC: 5900 /mm3
HCT: 36,Other tumor markers were within normal limits. Markers
for hepatitis A, C were all negative.
The patientwas thought having a Klatskin’s tumor and prepared
formajor surgery. At that time, obstructive jaundice developed (TB:
8.4mg/dl, DB: 5mg/dl). A second MR-MRCP was taken (about one
month later from the ﬁrst MR-MRCP). A 50×30mm mass extend-
ing from the left liver lobe entrance to the hilus, was detected.
Themasswas seperating completely central main biliary ducts and
http://dx.doi.org/10.1016/j.ijscr.2015.01.034
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Picture 1. Seperated bile ducts.
causing dilatations of intrahepatic biliary ducts. Common hepatic
duct couldn’t be seen in 1 cm from the biliary conﬂuence (Picture
1). Contrast enhanced diffusion series suggested a cholangiocarci-
noma. In addition, multiple lymph nodes (the largest 20×10mm)
in hilus and in front of inferior vena cava, were detected intraab-
dominally.
Tumor mass had been doubled and suspicious lymph nodes
had developed intraabdominally in one month. A type of lym-
phoma was suspected upon concerning biological behavior of
the tumor and the patient was referred for PET-CT and biopsy
after biliary drainage with 3 percuteneous transhepatic cholan-
giography (PTC) catheters into right anterior, right posterior
and left bile ducts.
After biliarydrainage the labarotuaryvalueswereTB:mg/dl,DB:
0.9mg/dl,AST: 86 U/L, ALT: 132 U/L, ALP: 429 U/L, GGT: 115 U/L.
PET-CT at that time revealed a tumoral mass of
50×35mm in dimensions with a FDG involvement
of SUD MAX: 19 (Picture 2).
A tumor tru-cut biopsy was performed by interventional radi-
ology department and pathological examinations revealed as
highgrade large B-cell NHL with CD 20(+) staining and Ki-67 pro-
liferation index: 60% (Picture 3).
The patient was referred to hematology and oncology
department and treated with 4 cycles of R-CHOP (ritux-
imab/cyclophosphamide/doxorubicine/vincristine/prednisolone).
Complete regresion was achieved 5 months later with control
PET-CT (Picture 4) and MR-MRCP (Picture 5). PTC catheters were
clamped a week and taken out after the control laboratory values
which were all within normal limits.
Picture 2. PET-CT of tumor.
Picture 3. Ki-67 proliferation index 60%.
Picture 4. Complete cure after chemotherapy in PET-CT.
Picture 5. Normalised anatomy of bile ducts in MR-MRCP.
The patient is followed up routinely with 4month- intervals for
a year. Recurrence has not been detected.
3. Discussion
Extrahepatic biliary primary NHL’s have similar features and
ﬁndings with cholangiocarcinoma in terms of imaging modali-
ties, clinical and laboratory ﬁndings [4]. In the literature there are
no results enough to make a differential diagnosis. However, in
lymhomas LDH level is high and CA 19–9 level is normal. As in our
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case, -when there is a rapid growing of tumor into a doubling size
in one month, it must be kept in mind that a lyphoma may arise
from the biliary system.Most of cases are pathologically diagnosed
after major surgery and chemotherapy is continued. An accurate
diagnosis can prevent unnecessary surgical intervention.
4. Conclusion
Primary liver lymphoma arising from the bile ducts cannot
be differentiated radiologically from Klatskin’s tumor. In terms of
tumor behavior, if there is a rapid growing of tumoral mass, it must
be kept in mind that it would be a lymphoma. Since the treat-
ment is totally different in lymphomas, unneccessary surgery can
be prevented upon suspicion.
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